This method identifies brain connectivity changes in Alzheimer’s disease, suggesting advanced diagnostic tools.
This article is motivated by the challenge of identifying interpretable brain functional connectivity biomarkers for Alzheimer's disease (AD) progression using high-dimensional functional magnetic resonance imaging (fMRI) data, where predictors comprise both heterogeneous disease-stage activation patterns and strongly similar functional connections. We propose a unified statistical method, called Sparse Multi-task Adaptive Regularization Truncation (SMART), to simultaneously address three critical challenges: (1) High dimensionality is resolved through an ℓ 1 ₁ -penalty ( λ 1 λ₁ ) that selects sparse, stage-distinct functional connections; (2) Disease-stage heterogeneity is accommodated via an ℓ 2 ₂ -penalty ( λ 2 λ₂ ) that maintains stable activation patterns across tasks; (3) Connection collinearity is mitigated using a truncated ℓ 2 ₂ penalty (TLP; λ 3 , τ λ₃,τ ) that adaptively groups edges with similar cross-task profiles without pre-specified structure. SMART offers key advantages over existing methods: Its joint regularization naturally handles smooth activation patterns across stages, while the TLP's dual parameters ( τ τ for adaptive grouping threshold, λ 3 λ₃ for sparsity control) provide a principled trade-off between biological fidelity and model complexity. Computationally, we develop a DC-ADMM algorithm that transforms the optimization into tractable subproblems, establishing finite-step convergence to KKT points. Comprehensive simulation studies and real-data analysis of AD neuroimaging data demonstrate SMART's superior accuracy in connectivity biomarker identification, enhanced stability in feature selection, and improved interpretability for AD cohort studies. An accompanying R package, SMART, is available on GitHub ( https://github.com/LDstat/SMART).
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: